AIM ImmunoTech Inc. (AIM)
NYSEAMERICAN: AIM · Real-Time Price · USD
0.520
+0.004 (0.85%)
At close: Apr 28, 2026, 4:00 PM EDT
0.530
+0.010 (1.92%)
Pre-market: Apr 29, 2026, 4:41 AM EDT
AIM ImmunoTech Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 4 | 3 | 13 | 21 | 15 | 44 | |
| Market Cap Growth | 92.58% | -74.47% | -41.22% | 43.27% | -65.93% | -39.56% | |
| Enterprise Value | 6 | 3 | 9 | 0 | -20 | -9 | |
| Last Close Price | 0.52 | 1.13 | 19.78 | 43.95 | 31.16 | 91.91 | |
| PS Ratio | 48.15 | 36.64 | 74.28 | 106.36 | 106.36 | 326.08 | |
| PB Ratio | - | -0.33 | -9.55 | 2.10 | 0.39 | 0.77 | |
| P/TBV Ratio | - | - | - | 2.97 | 0.42 | 0.81 | |
| EV/Sales Ratio | 69.16 | 35.83 | 51.93 | 2.45 | - | - | |
| Debt / Equity Ratio | -0.50 | -0.50 | -2.22 | 0.07 | 0.02 | 0.00 | |
| Net Debt / Equity Ratio | -0.19 | -0.19 | 0.78 | -1.21 | -0.87 | -0.85 | |
| Net Debt / EBITDA Ratio | -0.16 | -0.16 | 0.05 | 0.39 | 1.70 | 2.96 | |
| Net Debt / FCF Ratio | -0.17 | -0.17 | 0.07 | 0.58 | 2.06 | 3.44 | |
| Asset Turnover | 0.01 | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 | |
| Quick Ratio | 0.49 | 0.49 | 0.42 | 1.65 | 26.35 | 74.16 | |
| Current Ratio | 0.53 | 0.53 | 0.44 | 1.68 | 26.69 | 74.61 | |
| Return on Equity (ROE) | - | - | -388.69% | -118.93% | -40.79% | -32.37% | |
| Return on Assets (ROA) | -101.32% | -101.32% | -88.30% | -66.64% | -25.36% | -17.44% | |
| Return on Capital Employed (ROCE) | 2638.90% | 2638.90% | 2132.90% | -297.50% | -50.90% | -29.90% | |
| Earnings Yield | -329.44% | -432.94% | -137.15% | -134.80% | -129.66% | -43.45% | |
| FCF Yield | -258.61% | -339.86% | -118.04% | -98.98% | -107.98% | -31.82% | |
| Buyback Yield / Dilution | -188.95% | -188.95% | -15.18% | -1.12% | -1.49% | -48.67% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.